IQV FY 2024 Earnings — IQVIA Holdings Inc. Revenue & Financial Results | Market Cap Arena

IQVIQVIA Holdings Inc.

$30B

FY 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$15.4B+2.8% YoY

Gross Profit

$5.4B34.9% margin

Operating Income

$2.2B14.3% margin

Net Income

$1.4B8.9% margin

EPS (Diluted)

$7.49

Cash Flow

Operating Cash Flow

$2.7B

Free Cash Flow

$2.1B

Stock-Based Comp.

$206M

Balance Sheet

Total Assets

$26.9B

Total Liabilities

$20.8B

Stockholders' Equity

$6.1B

Cash & Equivalents

$1.7B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15.4B	$15.0B	+2.8%
Gross Profit	$5.4B	$5.2B	+2.6%
Operating Income	$2.2B	$2.0B	+11.4%
Net Income	$1.4B	$1.4B	+1.1%